Viridian Beta Carotene (Mixed Carotenoid Complex) 30 capsules Maximize

Viridian Beta Carotene (Mixed Carotenoid Complex) 30 capsules

Viridian Beta Carotene Capsules - A powerful combination of the carotenoid family. This potency equals 25,000iu vitamin A activity.

More details

30 Caps

R 175.00



Beta Carotene Mixed Carotenoid Complex Veg Caps

INGREDIENTS: one vegetarian capsule provides:

Natural Beta Carotene/Carotenoid Mix (from D Salina)           15mg

Providing (typical analysis):

Beta Carotene                           15mg

Cryptoxanthin                            117ug

Alpha Carotene                         474ug

Zeaxanthin                                96ug

Lutein                                        75ug

In a base of alfalfa, spirulina & bilberry.

Disclaimer: All information contained on this website is for information only and should not be used to diagnose, prevent, treat or cure any disease, health or medical condition. The products (food supplements) are not intended to diagnose, prevent, treat or cure any health or medical condition. Do not exceed stated dose or use with prescribed medication unless advised by a doctor or medical practitioner. Do not take if pregnant or lactating. Keep out of reach of children. Consult doctor for all medical advice.

Beta Carotene Complex

Carotenes represent the most widespread group of naturally occurring pigments in nature.  There are over 600 carotenoids with only 30 to 50 having vitamin A activity.  Carotenes are intensely coloured (red and yellow) group of fat soluble compounds.  Beta carotene would appear to have the highest pro-vitamin A activity.  This Beta carotene formula uses a natural source of synergistic carotenoids derived from one of nature’s richest sources, the sea algae DUNALIELLA SALINA.                      

  • ANTIOXIDANT PROTECTION - Epidemiological studies have shown that people with high intakes of beta-carotene or high blood levels of this nutrient have a reduced risk of various diseases. (van Poppel and Goldbohm, 1995).

The chemical abilities of beta-carotene to quench singlet oxygen and to inhibit peroxyl free radical reactions are well-established (Sies and Stahl, 1995). In addition to this antioxidant property, beta-carotene and some other carotenoids may play an important role in facilitating normal cell-to-cell communication through gap junctions (Acevedo and Bertram, 1995).

Because many carcinogens inhibit gap junction communications (Gregus and Klaassen, 1996), protection of this activity by dietary substances could be an important function.

  • SKIN HEALTH – prolonged vitamin A deficiency results in night blindness, increased rate of infection and the characteristic signs of follicular hyperkeratosis (build-up of cellular debris in the hair follicles, giving the skin a goose-bump appearance; occurs most on the back of the upper arm).  Beta carotene appears to act as a natural pre-tanning aid and having protective effects against UV damage.


  • VISUAL HEALTH – vitamin A is found in four kinds of photo-pigments within the retina, it plays a crucial role in the function of rods and cones needed for the transmission of the visual impulse.  Poor adaptation to changes in light and poor vision at night, are some of the initial findings in low vitamin A states.


  • IMMUNE FUNCTION – carotenes exert immune-enhancing effects independent of any vitamin A activity.  Oral beta carotene has been shown to significantly increase the frequency of T4 helper/inducer cells by 30% after 7 days.  The T4 lymphocytes play a critical role in determining host immune status.  Beta carotene appears to enhance thymus function and increase interferon’s stimulatory effects on anti-viral aspects of the immune system.



Supplementation ranges from 15mg (25,000 iu) for general health, up to 300,000iu in treatment programs.

Beta-carotene is considered to be virtually non-toxic because humans tolerate high dietary dosages without apparent harm, and animal studies also fail to find any toxic effects (Bendich, 1988; Hathcock et al., 1990; Diplock, 1995). Standard toxicological tests, including teratogenic, mutagenic and carcinogenic assay, have been performed on beta-carotene without any evidence of harmful effects. There is no evidence that conversion of beta-carotene to vitamin A contributes to vitamin A toxicity, even when beta-carotene is ingested in large amounts (Olson, 1994).

The only documented biological effect of high beta carotene intakes has been discoloration of the skin related to hyper-carotenemia, but this occurs only at extremely high intake levels. Intakes as high as 180 mg per day have been given to humans for several months without observed adverse effects other than skin colour changes (Mathews-Roth, 1986).

Potential applications

Cataracts / macular degeneration (lutein & zeaxanthin)

Carotenoids are likely to be beneficial for acne and hyperkeratotic disorders.

Colds, respiratory infections, cardiovascular protection, photosensitivity (e.g. solar urticaria), dry eyes, preventing damage through sun exposure, vaginal candidiasis.  Ailments of the mucosal surface (epithelial cells). 

Cystic fibrosis – upwards of 15mg beta-carotene per day have been shown to suppress lipid peroxidation

Cognitive function in the elderly may be associated with carotene status.

Beta carotene is required for healthy corpus luteum development, and so is important for healthy reproduction and may help prevent ovarian cysts.


Known contraindications

High vitamin A intake is contra-indicated in pregnancy, whereas the non-toxic carotenoids are suitable for supplementation. 


The conversion of carotenes to vitamin A depends on several factors, including protein status, thyroid hormones, zinc, and vitamin C.  The conversion rate diminishes as carotene intake increases and when serum retinol levels are adequate.

The cleavage of vitamin Beta carotene into retinol requires vitamin E.

Vitamin A appears to increase the bioavailability of inorganic iron and improve haemoglobin production.


Lutein / zeaxanthinObservational studies have noted that higher dietary intake of lutein and zeaxanthin is related to reduced risk of cataracts and age-related macular degeneration, two eye conditions for which there is minimal options when it comes to effective prevention. Researchers speculate that these carotenoids may promote eye health through their ability to protect the eyes from light-induced oxidative damage and aging through both their antioxidant actions as well as their ability to filter out UV light.


Cryptoxanthin - Research suggests that cryptoxanthin may promote the health of the respiratory tract. Serum concentrations of this carotenoid have been found to be associated with improved lung function as measured by functional tests. People who smoke as well as those who inhale second hand smoke have been found to have lower levels of this carotenoid.


Alpha carotene - Research indicates that diets low in alpha-carotene and carotenoids can increase the body’s susceptibility to damage from free radicals. As a result, over the long term, alpha-carotene deficient diets may increase tissue damage from free radical activity, and increase risk of chronic diseases.


Useful links

Acne / skin protection – zinc complex, hemp seed oil, pycnogenol/grape seed extract, dandelion/burdock

Note  the natural active excipient, bilberry/organic alfalfa/organic spirulina base blend provides an array of additional trace minerals, antioxidants, phytonutrients and enzymes to assist in the delivery, transport, and overall nutritional value of this formula.



Michael Murray. 1996.  The Encyclopaedia of Nutritional Supplements.

Bowman and Russell. 2001. Present Knowledge in Nutrition.  Eighth Edition.James L. Groff, Sareen S. Gropper, Sara M. Hunt.  1995.  Advanced Nutrition and Human Metabolism. 2nd Edition.Wyatt KM,
Agarwal S, Rao AV. Carotenoids and chronic diseases. Drug Metabol Drug Interact 2000;17(1-4):189-210.

Alberg AJ, Chen JC, Zhao H, Hoffman SC, Comstock GW, Helzlsouer KJ.. Household exposure to passive cigarette smoking  and serum micronutrient concentrations.. Am J Clin Nutr 2000 Dec;72(6):1576-82.